Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
NCT06922669Recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jun 2025
- Primary completion
- Mar 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of methylprednisolone injection in drug induced liver injury (DILI) and hyperbilirubinemia (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Improvement of Drug-Induced Liver Injury at 4 weeks. Started Jun 2025; status: recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
drug induced liver injury (DILI)hyperbilirubinemia
Beyond the preview
Go deeper on NCT06922669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06922669.